Ivan M. Borrello - 19 Oct 2023 Form 4/A - Amendment Insider Report for Gamida Cell Ltd.

Role
Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
19 Oct 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
20 Oct 2023, 16:34:11 UTC
Date Of Original Report
10 Feb 2023
Previous filing
10 Feb 2023
Next filing
02 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMDA Ordinary Shares Award $0 +28,300 +708% $0.000000 32,300 19 Oct 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMDA Share Option (Right to Buy) Award $0 +56,600 $0.000000 56,600 19 Oct 2023 Ordinary Shares 56,600 $1.59 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit ("RSU") award was approved by the Board of Directors of the Issuer on February 8, 2023, subject to shareholder approval. The Issuer's shareholders approved the award at the annual general meeting of the shareholders on October 19, 2023.
F2 Represents an RSU award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.
F3 The option grant was approved by the Board of Directors of the Issuer on February 8, 2023, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on October 19, 2023.
F4 This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

This amendment is being filed solely to correct the transaction dates to October 19, 2023 and to correct the expiration date of the option grant to October 18, 2033.